Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Cash from Investing Activities (2022 - 2026)

Core Laboratories filings provide 5 years of Cash from Investing Activities readings, the most recent being -$3.4 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 539.25% to -$3.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$6.4 million, a 61.26% decrease, with the full-year FY2025 number at -$2.2 million, up 65.11% from a year prior.
  • Cash from Investing Activities hit -$3.4 million in Q1 2026 for Core Laboratories, up from -$3.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q3 2025 to a low of -$3.8 million in Q4 2025.
  • Median Cash from Investing Activities over the past 5 years was -$1.7 million (2024), compared with a mean of -$1.3 million.
  • Biggest five-year swings in Cash from Investing Activities: surged 587.37% in 2025 and later crashed 539.25% in 2026.
  • Core Laboratories' Cash from Investing Activities stood at $1.1 million in 2022, then plummeted by 331.19% to -$2.4 million in 2023, then crashed by 45.5% to -$3.6 million in 2024, then fell by 5.42% to -$3.8 million in 2025, then rose by 9.62% to -$3.4 million in 2026.
  • The last three reported values for Cash from Investing Activities were -$3.4 million (Q1 2026), -$3.8 million (Q4 2025), and $2.4 million (Q3 2025) per Business Quant data.